Home › Funds › READYSTATE ASSET MANAGEMENT LP › MIRM

READYSTATE ASSET MANAGEMENT LP position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

READYSTATE ASSET MANAGEMENT LP reported holding 5,534,000 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$20.5M, representing 0.99% of its reported portfolio and ranking #28 among its reported holdings. READYSTATE ASSET MANAGEMENT LP has disclosed MIRM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)5.53M sh
Reported value held$20.49M
Portfolio Weight0.99%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How READYSTATE ASSET MANAGEMENT LP's MIRM position evolved

READYSTATE ASSET MANAGEMENT LP first disclosed a stake in MIRM in Q2 2024 at 43,000,000 shares (US$57.8M). The position peaked in Q1 2026 at 28,000,000 shares, worth US$83.8M. Across 9 filings, READYSTATE ASSET MANAGEMENT LP increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,534,000 shares valued at US$20.5M — a reduction of -22,466,000 shares quarter over quarter.. Notable position changes include a 80% trim in Q2 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 43.00M $57.81M New
Q3 2024 46.00M $67.58M Add
Q4 2024 40.00M $61.05M Reduce
Q1 2025 35.00M $56.94M Reduce
Q2 2025 33.67M $59.79M Reduce
Q3 2025 30.17M $72.61M Reduce
Q4 2025 30.41M $78.61M Add
Q1 2026 28.00M $83.78M Reduce
Q2 2026 5.53M $20.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 62 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has READYSTATE ASSET MANAGEMENT LP held MIRM?

READYSTATE ASSET MANAGEMENT LP has disclosed MIRM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is READYSTATE ASSET MANAGEMENT LP's current position in MIRM?

As of Q2 2026, READYSTATE ASSET MANAGEMENT LP holds 5.53M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $20.49M, representing 0.99% of its reported portfolio and ranking #28.

Has READYSTATE ASSET MANAGEMENT LP been buying or selling MIRM?

In the latest 13F filing (Q2 2026), READYSTATE ASSET MANAGEMENT LP reduced its position in MIRM. The position peaked in Q1 2026 at 28.00M shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.